OPTIMIZERx Corporation (PINKSHEETS: OPRX) announced today that Meehan Capital Management Group, Inc. ("Meehan Capital") recently issued an equity report on the Company as part of a sponsored research agreement.

Meehan Capital is a Registered Investment Advisor that writes equity research and commentary on small cap companies. Under the terms of the agreement, OPTIMIZERx has paid Meehan Capital's research coverage fee, thereby allowing the report to be made available to the investing public free of charge.

The full report can be accessed at www.meehancapital.com/research.html.

Earlier this week, OPTIMIZERx announced that it launched its first television commercial, which is currently being featured nationally on AMC, the Travel Channel, MSNBC, Lifetime Movies and other strategic channels to millions of U.S. households.

The commercial shows how Americans can access savings on their rising prescription and healthcare costs, as well OPTIMIZERx's new drug discount card for those without prescription insurance.

To view the commercial, please visit: www.optimizerx.com/commercial/.

About OPTIMIZERx Corporation

OPTIMIZERx provides unique platforms to help patients better afford and comply to their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company's patient support website, www.OPTIMIZERx.com, and its permanent subscriber base, continue to grow each month and is quickly becoming the preferred way to access branded prescription savings and support programs. Additionally, OPTIMIZERx has developed OFFERx(TM) and ADHERxE(TM) to allow a more streamlined, effective way to create, promote and manage new trial or co-pay programs on behalf of brand-name pharmaceuticals and health care products.

About Meehan Capital

Meehan Capital Management Group, Inc., www.meehancapital.com, is a Florida-based Registered Investment Advisor. The firm began operations in 1999 and provides investment advisory services, including management and research on investment opportunities covering public securities and private equity, mutual funds, ETF and fixed income portfolios.

'SAFE HARBOR'

This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contacts: Tom Majerowicz 248-651-6568 Email Contact

OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more OptimizeRx Charts.
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more OptimizeRx Charts.